Lifemate India Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 07-07-2024
- Paid Up Capital ₹ 1.00 M
as on 07-07-2024
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.00 Cr
as on 07-07-2024
- Revenue 59.93%
(FY 2023)
- Profit 101.53%
(FY 2023)
- Ebitda -75.31%
(FY 2023)
- Net Worth 4.36%
(FY 2023)
- Total Assets -10.35%
(FY 2023)
About Lifemate India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹2.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Manish Kapoor, Amit Vig, Arun Kapoor, and One other member serve as directors at the Company.
- CIN/LLPIN
U29305DL2001PTC112359
- Company No.
112359
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2001
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lifemate India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Vig  | Director | 19-Dec-2020 | Current |
| Manish Kapoor | Director | 14-Feb-2014 | Current |
| Arun Kapoor | Director | 31-Mar-2017 | Current |
| Prem Kapoor | Director | 31-Mar-2017 | Current |
Financial Performance and Corporate Structure Insights of Lifemate India.
Lifemate India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.93% increase. The company also saw a substantial improvement in profitability, with a 101.53% increase in profit. The company's net worth moved up by a moderate rise of 4.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lifemate India?
In 2023, Lifemate India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kapbro Pharma Private LimitedActive 19 years 8 monthsManish Kapoor, Arun Kapoor and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Kotak Mahindra Bank Limited Creation Date: 27 May 2015 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Lifemate India?
Unlock and access historical data on people associated with Lifemate India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lifemate India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lifemate India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
